X-Therma
PrivateLast Round
Series B
Mar 13, 2024
Total Funding Raised
$44.37M
Company Overview
X-Therma operates in Healthcare & Life Sciences and is based in Hercules, California. Its latest recorded funding round was a Series B round in March 2024.
X-Therma is a biotechnology company that develops innovative biopreservation solutions, including ice-free, DMSO-free, sub-zero preservation and transport platforms for cells, tissues, and organs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Pharma Supply Chain, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
X-Therma Comparables
Compare X-Therma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bridge to Life | 82% | |
| CryoStasis Inc. | 82% | |
| Until Labs | 82% |
For institutional investors. Book with your work email.
X-Therma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 13, 2024 | ||||
| Series A | Dec 22, 2021 | ||||
| Grant | Dec 23, 2020 | ||||
| Grant | Sep 16, 2019 | ||||
| Angel | Aug 27, 2018 | ||||
Grant | Aug 21, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
X-Therma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Catalytic Impact Foundation | Series A |
| California Institute for Regenerative Medicine | Grant |
| VU Venture Partners | Series A |
| 2b AHEAD Ventures | Series A |
| Graphene Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2025
Attended the American Society of Nephrology's Kidney Week 2025.
- Dec 19, 2025
Featured in USA Today's Kidney Health campaign.
For institutional investors. Book with your work email.
X-Therma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about X-Therma's valuation, stock price, and market status.
Is X-Therma a public or private company?
X-Therma is a private company.
What is the current stock price of X-Therma?
X-Therma is a private company, so its shares have no public market price. Caplight tracks X-Therma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is X-Therma worth (valuation)?
Valuation information for X-Therma is not publicly available.
Can I buy X-Therma stock?
X-Therma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was X-Therma's last funding round?
X-Therma's most recent funding round was Series B on March 13, 2024.
Who are the main investors in X-Therma?
Key investors in X-Therma include U.S. Department of Health and Human Services, NIH RADx, Catalytic Impact Foundation, California Institute for Regenerative Medicine, VU Venture Partners.
Will X-Therma IPO soon?
No public IPO plans have been announced for X-Therma.
How can I track X-Therma secondary market activity?
Caplight tracks bids, offers, and trades in X-Therma's shares on secondary markets.